Results: 23

Expression Levels of the CA9, WT1, and PRAME genes and genotyping-associated antigens for the diagnosis and prognosis of colorectal cancer

Background: Colorectal cancer (CRC) is the third most prevalent type of cancer worldwide, and is one of the major health problems in Asia, Africa, Europe, and America. The tumor antigens recently are of interesting indicators as diagnostic and prognostic tools, The aim of the present study is to detect t...

Immunohistochemical Markers in the Differential Diagnosis of Melanoma and Nevus in Humans

Int. j. morphol; 39 (5), 2021
SUMMARY: Immunohistochemistry allows in situ detection of cell and extracellular components through specific antibodies. The objective was to compare the immunohistochemical expression patterns of the S-100, HMB-45 and MART-1 proteins for differential diagnosis of malignant melanoma and melanocytic nevus...

Evaluation of squamous cell carcinoma antigen 1 expression in oral squamous cell carcinoma (tumor cells and peritumoral T-lymphocytes) and verrucous carcinoma and comparison with normal oral mucosa

J. appl. oral sci; 29 (), 2021
Abstract Background: Squamous cell carcinoma antigen (SCCA) is used as a prognostic marker for recurrence of squamous cell carcinoma in various sites, including head and neck. Studies suggest that its high serum levels are correlated to some clinical features, such as nodal metastasis. However, it is st...

Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis

Int. braz. j. urol; 46 (5), 2020
ABSTRACT Background: The diagnostic value and suitability of prostate cancer antigen 3 (PCA3) for the detection of prostate cancer (PCa) have been inconsistent in previous studies. Thus, the aim of the present meta-analysis was performed to systematically evaluate the diagnostic value of PCA3 for PCa. ...

Anticuerpos conjugados a fármaco: la nueva generación de terapias biotecnológicas contra el cáncer

Gac. méd. Méx; 156 (3), 2020
Resumen Los anticuerpos terapéuticos son proteínas recombinantes empleadas en el tratamiento del cáncer. Existe una nueva generación de anticuerpos monoclonales con actividad contra las células cancerosas, conocidos como anticuerpos conjugados a fármacos. Estas moléculas están integradas por tres...

Prognostic significance of inflammation-based prognostic scoring in patients with upper urinary tract urothelial carcinoma

Int. braz. j. urol; 45 (3), 2019
ABSTRACT Objectives: To investigate whether Glasgow Prognostic Score has prognostic significance in patients with upper urinary urothelial carcinoma. Patients and methods: We retrospectively reviewed the clinical records of 74 patients with upper urinary urothelial carcinoma. We set the cut-off value f...

Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries

Clinics; 74 (), 2019
OBJECTIVES: Osteosarcoma of the jaw (OSAJ) is fundamentally different in clinical practice from its peripheral counterparts. Studies are difficult to conduct due to low incidence rates. The primary aim of this study was to provide for the first time a comprehensive retrospective analysis of the treatment...

PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population

Int. braz. j. urol; 44 (3), 2018
ABSTRACT Background: The association of prostate cancer antigen 3 (PCA3) polymorphism (SNP, rs544190G>A) with metastatic prostate cancer in European descent has been reported. Our aim of the current study was to re-validate the effect of PCA3 polymorphism on prostate cancer risk in an Eastern Chinese...

¿Es el PCA3 costoefectivo en Latinoamérica y el Caribe?

Salud pública Méx; 60 (1), 2018

Immunological-based approaches for cancer therapy

Clinics; 73 (supl.1), 2018
The immunologic landscape of tumors has been continuously unveiled, providing a new look at the interactions between cancer cells and the immune system. Emerging tumor cells are constantly eliminated by the immune system, but some cells establish a long-term equilibrium phase leading to tumor immunoediti...